NCT06688370View on ClinicalTrials.gov

The Performance and Safety of Petit Drill in the French Paediatric Population: a Post-market Clinical Follow-up Study.

TerminatedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

March 14, 2024

Primary Completion Date

November 7, 2024

Study Completion Date

November 7, 2024

Conditions
Sore-throatCough
Interventions
DEVICE

Petit Drill

Day 1: 2-4 doses, including one of the daily doses taken at bedtime. Days 2 and 3: 3 to 4 doses on days 2 and 3, including one of the daily doses taken at bedtime.

Trial Locations (1)

21000

Cen Experimental, Dijon

Sponsors

Collaborators (1)

CEN Biotech
All Listed Sponsors
collaborator

CEN Biotech

INDUSTRY

lead

Pierre Fabre Medicament

INDUSTRY

NCT06688370 - The Performance and Safety of Petit Drill in the French Paediatric Population: a Post-market Clinical Follow-up Study. | Biotech Hunter | Biotech Hunter